This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Registration

Researchers identify 4-gene signature to predict neonatal sepsis before symptoms

Oct 31 , 2024

Neonatal sepsis, affecting infants in their first 28 days, occurs in 2-3 per 100 live births globally, particularly impacting preterm and low-birth-weight neonates. Mortality rates can reach 17.6%, especially in low/middle-income countries, with sepsis being a leading cause of neonatal death.

The non-specific clinical signs often delay diagnosis, making timely treatment critical. Current diagnostic methods, including blood cultures, are insufficient, emphasizing the urgent need for specific biomarkers to identify sepsis early and accurately. Further research is essential to develop predictive biomarkers for timely intervention.

Among this cohort, 33 neonates were hospitalized within 28 days due to clinical signs consistent with sepsis. Of these, 21 were diagnosed with sepsis based on either blood culture results or clinical diagnosis, while the remaining 12 had localized infections without systemic signs. Septic neonates were categorized into early-onset sepsis EOS and late-onset sepsis LOS

Source: https://www.news-medical.net/news/20241031/Researchers-identify-4-gene-signature-to-predict-neonatal-sepsis-before-symptoms.aspx


Subscribe to our News & Updates